DELCO's Biotech Stock Letter "Best Buys" in November included Genetics Institute (GENIZ) up $22 per share in one day.ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Dec. 19, 1996--The DELCO DELCO Delaware County (Pennsylvania) DELCO Dayton Engineering Laboratory Company BIOTECH INVESTMENT LETTER formerly named "BIOVEST" announced that its biotech stocks "best buys" have been among the best biotech performers this quarter. Its top performers have risen as high as 126% since they were recommended by Steven P. Delco, president of Delco Scientific Resources, a biotech market research firm established in 1982 and the publisher of the DELCO BIOTECH LETTER. Among these superior performers recommended by Delco are Genetics Institute (GENIZ) which rose $22.75 per share for an increase of 33.07% in one day (December 18, 1996). This increase was the result of a $1.25 billion purchase by American Home For the American mortgage lender, see . The American Home is a center of intercultural exchange located in Vladimir, Russia. The home is designed to model a typical American suburban home and its main focus is the ESL school that provides lessons for Russian students. Products Corp. to acquire the remaining 40% of the company they do not already own. Other exceptional performers recommended by Delco in recent months include Protein Design Labs, Inc. (PDLI PDLI Protein Design Labs, Inc. PDLI Project Directive Line Item ) which has risen $18.84 per share, an increase of 126.61% since recommended, Agouron (AGPH), up a whopping $26.37 per share for a 75.6% increase in value, Immunex (IMNX) with a gain of $4.00 per share for an increase of 32.31%, Isis Pharmaceutical (ISIP ISIP Institute for Signal and Information Processing ISIP Intelligent Storage Interconnect Platform ISIP Intermediate-Size Inducer Pump ISIP Initiative for State Infrastructure Protection ISIP Information Sharing Integration Platform ISIP Integrated Signal/Information Processing ) another company recommended by Delco is up $3.25 per share for an increase of 21.13% and Novo Nordisk Wikipedia is not the place for advertisement or self-advertising. Novo Nordisk (, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest (NVO NVO no visible oestrus (see no visible estrus). Called also NVE. ) up $6.75 per share for an increase of 18.18%. The DELCO BIOTECH composite of recommended biotech stocks is up 26.44% since August with a composite gain of $84.62 per share. "The biotechnology industry has come of age," states Delco. "There are over 400 biotech drugs in FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clinical trials with about 20% of those drugs in the later phases of testing. Biotechnology is making a significant contribution to the growing demand for remedies in infectious and degenerative diseases." Delco's Biotech letter takes a long term approach to the industry. "Past performance is no guarantee for future results. In our opinion," Delco continues, "the key factors when looking to invest in biotechnology are corporate diversity, product flow, marketing capability and market potential." CONTACT: Delco Scientific Resources Steven Paul Delco, 505/243-0536 delcosci@labmart.com http://www.labmart.com/pages/stocks.htm |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion